Pre-made benchmark antibody with INN name
Virus-like particles (VLP) Platforms for immunogens, vaccines and drug carriers
Antibody-drug Conjugate (ADC): Pre-made ADC benchmark, MOA, Production and QC
Neutralizing antibodies of virus (SARS2, HIV, HBV, Rabies, RSV, Ebola, Influenza)
Immunoglobulin Fc receptors for Fc&Fc Receptor binding assay
ILIBRA-HuEasy Monoclonal antibody (mab) humanization service (fully humanized ab)
Single domain antibody (Nanobody)
SOCAIL MEDIA
GeneMedi provides pre-made research class therapeutic antibodies & Fusion Protein with WHO-INN name. The INN named antibodies & Fusion Protein are biosimilars expressed by mammalian cell line as a benchmark reference therapeutic antibody or Fusion Protein for cell culture, in vitro/in vivo assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Link to IMGT(Immunogenetics Information System)
Know more about INN named antibodies
Download about 
INN information from WHO
Product list
Filters
Sort results
Reset
Apply
Cat No. | Products Name (INN Index) | INN Name | Previous Name | Target | Format | Order |
|---|---|---|---|---|---|---|
Pre-Made Ponsegromab biosimilar, Whole mAb, Anti-GDF15 Antibody: Anti-GDF-15/MIC-1/MIC1/NAG-1/PDF/PLAB/PTGFB therapeutic antibody |
Ponsegromab |
NA |
GDF15 |
Whole mAb |
||
Pre-Made Porgaviximab biosimilar, Whole Mab: Anti-Zaire Ebolavirus GP therapeutic antibody |
Porgaviximab |
NA |
Zaire Ebolavirus GP |
Whole mAb |
||
Pre-Made Plonmarlimab biosimilar, Whole mAb, Anti-CSF2 Antibody: Anti-CSF/GMCSF therapeutic antibody |
Plonmarlimab |
NA |
CSF2 |
Whole mAb |
||
Pre-Made Praluzatamab biosimilar, Whole mAb, Anti-CD166/ALCAM Antibody: Anti-MEMD therapeutic antibody |
Praluzatamab |
NA |
CD166 |
Whole mAb |
||
Pre-Made Prasinezumab biosimilar, Whole mAb, Anti-SNCA Antibody: Anti-NACP/PARK1/PARK4/PD1 therapeutic antibody |
Prasinezumab |
NA |
SNCA |
Whole mAb |
||
Pre-Made Prezalumab biosimilar, Whole mAb, Anti-ICOSLG/B7RP1 Antibody: Anti-B7-H2/B7H2/B7h/CD275/GL50/ICOS-L/ICOSL/LICOS therapeutic antibody |
Prezalumab |
NA |
ICOSLG |
Whole mAb |
||
Pre-Made Pritoxaximab biosimilar, Whole Mab: Anti-Shiga Toxin Type 1 therapeutic antibody |
Pritoxaximab |
NA |
Shiga Toxin Type 1 |
Whole mAb |
||
Pre-Made Prolgolimab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibody |
Prolgolimab |
NA |
PDCD1 |
Whole mAb |
||
Pre-Made Pucotenlimab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibody |
Pucotenlimab |
NA |
PDCD1 |
Whole mAb |
||
Pre-Made Quavonlimab biosimilar, Whole mAb, Anti-CTLA4/CTLA-4 Antibody: Anti-CD/GSE/GRD4/ALPS5/CD152/IDDM12/CELIAC3 therapeutic antibody |
Quavonlimab |
NA |
CTLA4 |
Whole mAb |
||
Pre-Made Quetmolimab biosimilar, Whole mAb, Anti-CX3CL1 Antibody: Anti-ABCD-3/C3Xkine/CXC3/CXC3C/NTN/NTT/SCYD1/fractalkine/neurotactin therapeutic antibody |
Quetmolimab |
NA |
CX3CL1 |
Whole mAb |
||
Pre-Made Quilizumab biosimilar, Whole Mab: Anti-IGHE/IgE therapeutic antibody |
Quilizumab |
NA |
IGHE |
Whole mAb |
||
Pre-Made Racotumomab biosimilar, Whole Mab: Anti-Idiotope of Anti-NeuGc-ganliosides therapeutic antibody |
Racotumomab |
NA |
Idiotope of anti-NeuGc-ganliosides |
Whole mAb |
||
Pre-Made Radretumab biosimilar, di-scFv + CH4: Anti-FN extra domain B therapeutic antibody |
Radretumab |
NA |
FN extra domain B |
di-scFv + CH4 |
||
Pre-Made Rafivirumab biosimilar, Whole Mab: Anti-RV Antigenic Site III therapeutic antibody |
Rafivirumab |
NA |
RV Antigenic Site III |
Whole mAb |
||
Pre-Made Ragifilimab biosimilar, Whole mAb, Anti-TNFRSF18 Antibody: Anti-AITR/CD357/ENERGEN/GITR/GITR-D therapeutic antibody |
Ragifilimab |
NA |
TNFRSF18 |
Whole mAb |
||
Pre-Made Ralpancizumab biosimilar, Whole mAb, Anti-PCSK9 Antibody: Anti-FH3/FHCL3/HCHOLA3/LDLCQ1/NARC-1/NARC1/PC9 therapeutic antibody |
Ralpancizumab |
NA |
PCSK9 |
Whole mAb |
||
Pre-Made Ramucirumab biosimilar, Whole mAb, Anti-KDR Antibody: Anti-FLK1/CD309/VEGFR/VEGFR2 therapeutic antibody |
Ramucirumab |
NA |
KDR |
Whole mAb |
||
Pre-Made Ranevetmab biosimilar, Canine Whole mAb, Anti-NGFB/NGF Antibody: Anti-HSAN5 therapeutic antibody |
Ranevetmab |
NA |
NGFB |
Canine Whole mAb |
||
Pre-Made Ranibizumab biosimilar, Fab, Anti-VEGFA Antibody: Anti-VPF/VEGF/MVCD1 therapeutic antibody |
Ranibizumab |
NA |
VEGFA |
Fab |
||
Pre-Made Ravagalimab biosimilar, Whole mAb, Anti-CD40 Antibody: Anti-p50/Bp50/CDW40/TNFRSF5 therapeutic antibody |
Ravagalimab |
NA |
CD40 |
Whole mAb |
||
Pre-Made Ravulizumab biosimilar, Whole mAb, Anti-C5/CO5 Antibody: Anti-CPAMD4/ECLZB therapeutic antibody |
Ravulizumab |
NA |
C5 |
Whole mAb |
||
Pre-Made Recaticimab biosimilar, Whole mAb, Anti-PCSK9 Antibody: Anti-FH3/FHCL3/HCHOLA3/LDLCQ1/NARC-1/NARC1/PC9 therapeutic antibody |
Recaticimab |
NA |
PCSK9 |
Whole mAb |
||
Pre-Made Refanezumab biosimilar, Whole mAb, Anti-MAG Antibody: Anti-GMA/S-MAG/SIGLEC-4A/SIGLEC4A/SPG75 therapeutic antibody |
Refanezumab |
NA |
MAG |
Whole mAb |
||
Pre-Made Relatlimab biosimilar, Whole mAb, Anti-LAG3 Antibody: Anti-CD223 therapeutic antibody |
Relatlimab |
NA |
LAG3 |
Whole mAb |
||
Pre-Made Relfovetmab biosimilar, Feline Whole mAb, Anti-NGFB/NGF Antibody: Anti-HSAN5 therapeutic antibody |
Relfovetmab |
NA |
NGFB |
Feline Whole mAb |
||
Pre-Made Remtolumab biosimilar, Bispecific Dual Variable Domain IG: Anti-IL17A/IL17;TNFA/TNF therapeutic antibody |
Remtolumab |
NA |
IL17A,TNFA |
Bispecific Dual Variable Domain IG |
||
Pre-Made Reslizumab biosimilar, Whole mAb, Anti-IL5 Antibody: Anti-EDF/IL-5/TRF therapeutic antibody |
Reslizumab |
NA |
IL5 |
Whole mAb |
||
Pre-Made Retifanlimab biosimilar, Whole mAb, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibody |
Retifanlimab |
NA |
PDCD1 |
Whole mAb |
||
Pre-Made Retlirafusp biosimilar, Whole mAb Fusion, Anti-CD274/PD-L1 Antibody: Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1 therapeutic antibody |
Retlirafusp |
NA |
CD274 |
Whole mAb Fusion |
||
Pre-Made Revdofilimab biosimilar, Whole mAb, Anti-TNFRSF4/CD134 Antibody: Anti-ACT35/IMD16/OX40/TXGP1L therapeutic antibody |
Revdofilimab |
NA |
TNFRSF4 |
Whole mAb |
||
Pre-Made Rilotumumab biosimilar, Whole mAb, Anti-HGF Antibody: Anti-DFNB39/F-TCF/HPTA/SF therapeutic antibody |
Rilotumumab |
NA |
HGF |
Whole mAb |
||
Pre-Made Rinucumab biosimilar, Whole mAb, Anti-PDGFRB Antibody: Anti-IMF1/KOGS/IBGC4/JTK12/PDGFR/PENTT/CD140B/PDGFR1/PDGFR-1 therapeutic antibody |
Rinucumab |
NA |
PDGFRB |
Whole mAb |
||
Pre-Made Ripertamab biosimilar, Whole mAb, Anti-MS4A1/CD20 Antibody: Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic antibody |
Ripertamab |
NA |
MS4A1 |
Whole mAb |
||
Pre-Made Risankizumab biosimilar, Whole mAb, Anti-IL23A/IL23 Antibody: Anti-IL23P19/P19/SGRF therapeutic antibody |
Risankizumab |
NA |
IL23A |
Whole mAb |
||
Pre-Made Rituximab biosimilar, Whole mAb, Anti-MS4A1/CD20 Antibody: Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic antibody |
Rituximab |
NA |
MS4A1 |
Whole mAb |
||
Pre-Made Rivabazumab biosimilar, Fab: Anti-PcrV type III secretion system therapeutic antibody |
Rivabazumab |
NA |
PcrV type III secretion system |
Fab |
||
Pre-Made Robatumumab biosimilar, Whole mAb, Anti-IGF1R Antibody: Anti-IGFR/CD221/IGFIR/JTK13 therapeutic antibody |
Robatumumab |
NA |
IGF1R |
Whole mAb |
||
Pre-Made Roledumab biosimilar, Whole mAb, Anti-RHD Antibody: Anti-CD240D/DIIIc/HDFNRH/RH30/RHCED/RHDVA(TT)/RHDel/RHPII/RHXIII/Rh4/RhII/RhK562-II/RhPI therapeutic antibody |
Roledumab |
NA |
RHD |
Whole mAb |
||
Pre-Made Rolinsatamab biosimilar, Whole mAb ADC, Anti-PRLR Antibody: Anti-HPRL/MFAB/RI-PRLR/hPRLrI therapeutic antibody |
Rolinsatamab |
NA |
PRLR |
Whole mAb ADC |
||
Pre-Made Romilkimab biosimilar, Bispecific Dual Variable Domain IG, Anti-IL13;IL4 Antibody: Anti-IL-13/P600;BCGF-1/BCGF1/BSF-1/BSF1/IL-4 therapeutic antibody |
Romilkimab |
NA |
IL13,IL4 |
Bispecific Dual Variable Domain IG |
||
Pre-Made Romosozumab biosimilar, Whole mAb, Anti-SOST Antibody: Anti-CDD/DAND6/VBCH therapeutic antibody |
Romosozumab |
NA |
SOST |
Whole mAb |
||
Pre-Made Rontalizumab biosimilar, Whole mAb, Anti-IFNA1 Antibody: Anti-IFL/IFN3/leIF DD therapeutic antibody |
Rontalizumab |
NA |
IFNA1 |
Whole mAb |
||
Pre-Made Rosmantuzumab biosimilar, Whole mAb, Anti-RSPO3 Antibody: Anti-CRISTIN1/PWTSR/THSD2 therapeutic antibody |
Rosmantuzumab |
NA |
RSPO3 |
Whole mAb |
||
Pre-Made Rosopatamab biosimilar, Whole mAb, Anti-FOLH1/GCPII Antibody: Anti-FGCP/FOLH/GCP2/NAALAD1/PSM/PSMA/mGCP therapeutic antibody |
Rosopatamab |
NA |
FOLH1 |
Whole mAb |
||
Pre-Made Rovalpituzumab biosimilar, Whole mAb ADC, Anti-DLL3 Antibody: Anti-SCDO1 therapeutic antibody |
Rovalpituzumab |
NA |
DLL3 |
Whole mAb ADC |
||
Pre-Made Rozanolixizumab biosimilar, Whole mAb, Anti-FCGRT Antibody: Anti-FCRN/FcgammaRn/alpha-chain therapeutic antibody |
Rozanolixizumab |
NA |
FCGRT |
Whole mAb |
||
Pre-Made Rozibafusp biosimilar, Whole mAb Fusion, Anti-ICOS Antibody: Anti-AILIM/CD278/CVID1 therapeutic antibody |
Rozibafusp |
NA |
ICOS |
Whole mAb Fusion |
||
Pre-Made Runimotamab biosimilar, Bispecific mAb, Anti-ERBB2/HER2;CD3E Antibody: Anti-CD340/MLN 19/NEU/NGL/TKR1/VSCN2;T3E/TCRE/IMD18 therapeutic antibody |
Runimotamab |
NA |
ERBB2,CD3E |
Bispecific mAb |
||
Pre-Made Ruplizumab biosimilar, Whole mAb, Anti-CD40LG Antibody: Anti-IGM/IMD3/TRAP/gp39/CD154/CD40L/HIGM1/T-BAM/TNFSF5/hCD40L therapeutic antibody |
Ruplizumab |
NA |
CD40LG |
Whole mAb |
